Retraction

Overexpression of miR–708 and Its Targets in the Childhood Common Precursor B-cell ALL

Retraction Details

Retraction Reason:

Duplication of/in Article

Nature of Retraction:

Retraction

Retraction Notice:
10.1002/pbc.26498

Citations (30)

30
Total Citations
23
Post-Retraction
(76.7%)
6
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
7 Within 1 year
12 After 2+ years
2937 Days since retraction (latest)
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Mar 2025
2937 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jan 2023
2147 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Apr 2022
1893 days after retraction
CircNPM1 strengthens Adriamycin resistance in acute myeloid leukemia by mediating the miR-345-5p/FZD5 pathway
Jie Ding, Xiaochun Zhang, Jianan Xue et al. (7 authors)
Central European Journal of Immunology Open Access
Published: Jan 2021
16 citations
1417 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jan 2021
1417 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Dec 2020
1386 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Sep 2020
1295 days after retraction
Paper citing miR-664 negatively regulates PLP2 and promotes cel...
Unknown Authors
Unknown Journal
Published: Jun 2020
1226 days after retraction
MicroRNA-345 functions as a tumor suppressor via targeting ZEB2 in oral squamous cell carcinoma
Jing Wu, Jun Cao, Xiaoyu Li et al. (5 authors)
Archives of Oral Biology
Published: Apr 2020
12 citations
1165 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jan 2020
1051 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: May 2019
835 days after retraction
RETRACTED: Protective effect of down-regulated microRNA-27a mediating high thoracic epidural block on myocardial ischemia-reperfusion injury in mice through regulating ABCA1 and NF-κB signaling pathway
Jinyu Liu, Jie Shang, Xiaodong Mu et al. (4 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Feb 2019
23 citations
738 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Oct 2018
619 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Oct 2018
595 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Sep 2018
564 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Aug 2018
556 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jan 2018
321 days after retraction
Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma
Lara Elis Alberici Delsin, Gabriela Molinari Roberto, Paola Fernanda Fedatto et al. (7 authors)
Pathology & Oncology Research
Published: Sep 2017
16 citations
222 days after retraction
Physiological and Pathological Functions of Mammalian MicroRNAs
Xuekai Ma, L. Wang, Zhi Cao et al. (8 authors)
Elsevier eBooks
Published: Aug 2017
182 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jul 2017
161 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jul 2017
154 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jul 2017
154 days after retraction
miRNA-708 functions as a tumour suppressor in hepatocellular carcinoma by targeting SMAD3
Qi Li, Sheng Li, Yaolu Wu et al. (4 authors)
Oncology Letters Open Access
Published: Jun 2017
34 citations
126 days after retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Feb 2016
378 days before retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jan 2016
408 days before retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Dec 2015
421 days before retraction
Paper citing miR-664 negatively regulates PLP2 and promotes cel...
Unknown Authors
Unknown Journal
Published: Oct 2015
502 days before retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Jul 2015
594 days before retraction
Paper citing Overexpression of miR–708 and Its Targets in the C...
Unknown Authors
Unknown Journal
Published: Sep 2014
887 days before retraction
Quick Stats
Total Citations: 30
Years Since Retraction: 8.8 years
Open Access: Yes
Last Checked: Never
Related Papers
Response: Early-Stage Hodgkin Lymphoma
Pediatric Blood & Cancer • 0 citations